Nexalin Technology, Inc. (NXL)

NASDAQ: NXL · USD

$1.63

-0.01 (-0.6%)· Recorded snapshot

Market cap	1.4M
Revenue (ttm)	217.2K
Net income (ttm)	-9M
EPS (ttm)	-$13.9
Shares out	829.4K
Volume	38,536
Beta	4.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 217.2K
Net income (ttm): -9M
EPS (ttm): -$13.9
Market cap: 1.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-240.3

P25 -113.8P50 -46.5P75 -0.9

ROIC-152.4

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All NXL indicators

Market & fundamental data

Available fields

195

Groups with data

Currency

USD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001527352
Company name	Nexalin Technology, Inc.
Country	United States
Country code	US
CUSIP number	65345B300
Earnings date	2026-11-13
Employees	8
Employees change	2
Employees growth	33.33%
Enterprise value	$346,961
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Medical Devices
IPO date	2022-09-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US65345B3006
Last 10-K release date	2026-03-25
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2026-08-31
Last stock split type	Reverse
Market cap	$1.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$1.63
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	NXL
U.S. state	Texas
Website	https://www.nexalin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-854%
EV/Sales	1.81x
FCF / EV yield	-1,573.74%
FCF yield	-442.08%
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.79x
P/S ratio	6.44x
Price / tangible book value	3.33x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	86.16%
Operating margin	-4,202.54%
Pretax margin	-4,139.38%
Profit per employee	$-1.1M
Revenue per employee	$27,144
ROA	-119.22%
ROA (5Y)	-239.35%
ROCE	-600.62%
ROE	-240.25%
ROIC	-152.45%
SBC / revenue	1,290.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	58.25%
Gross profit growth (Q)	-81.37%
Gross profit growth 3Y	-24.76%
Gross profit growth 5Y	12.88%
Net income growth years	0
Revenue growth	24.22%
Revenue growth (Q)	-82.77%
Revenue growth (QoQ)	-18.66%
Revenue growth 3Y	-30.61%
Revenue growth 5Y	10.22%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-49,276
Depreciation and amortization	$45,530
EBIT	$-9.1M
EBITDA	$-9.1M
EPS	$-13.92
FCF per share	$-7.45
Financing cash flow	$1.4M
Free cash flow	$-6.2M
Free cash flow minus SBC	$-9M
Gross profit	$187,097
Investing cash flow	$5.3M
Net cash flow	$573,638
Net income	$-9M
Operating cash flow minus SBC	$-8.9M
Operating income	$-9.1M
Revenue	$217,155
Stock-based compensation	$2.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-49.51
Book value per share	$2.07
Debt / equity	0
Long-term assets	$1.1M
Long-term liabilities	$0
Net cash (debt)	$1M
Net cash / market cap	71.91%
Net cash growth	-82.65%
Net debt / equity	-0.66
Piotroski F-Score	3
Property, plant and equipment	$42,432
Shareholders' equity	$1.5M
Tangible book value	$419,782
Tangible book value per share	$0.57
Total assets	$3M
Total cash	$1M
Total debt	$0
Total liabilities	$1.5M
WACC	26.86%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.05
Current assets	$1.9M
Current liabilities	$1.5M
Current ratio	1.25
Inventory turnover	0.13
Net working capital	$-627,608
Quick ratio	0.71
Working capital	$377,350
Working capital turnover	0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-52%
Dividend yield	0%
Shareholder yield	-52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$9.70
1D price change	-0.61%
1M price change	-61.05%
1M total return	-61.05%
1W price change	-20.09%
1W total return	-20.09%
1Y price change	-96.15%
1Y return CAGR	-96.16%
1Y total return	-96.15%
20-day SMA	$3.20
200-day SMA	$11.09
3M price change	-87.1%
3M total return	-87.1%
3Y price change	-81.86%
3Y return CAGR	-43.38%
3Y total return	-81.86%
50-day SMA	$4.94
50-day SMA vs 200-day SMA	50under200
52-week high	$49.50
52-week high date	2025-10-30
52-week low	$1.59
52-week low date	2026-10-27
6M price change	-85.93%
6M total return	-85.93%
All-time high	$134.70
All-time high date	2024-12-04
All-time low	$1.59
All-time low date	2026-10-27
Average true range (ATR)	$0.57
Average volume	3.3M
Beta (1Y)	3.05
Beta (2Y)	1.88
Beta (5Y)	4.11
Change from 52-week high	-96.71%
Change from 52-week low	2.52%
Change from all-time high	-98.73%
Change from all-time low	7.55%
Change from open	0%
Day's gap	-0.61%
Dollar volume	$62,814
High price	$1.63
Low price	$1.63
Monthly RSI	39.21
Open price	$1.63
Premarket change	6.1%
Premarket close	$1.64
Premarket price	$1.74
Previous close	$1.64
Price vs 150-day SMA	-82.38%
Price vs 20-day SMA	-46.61%
Price vs 200-day SMA	-84.59%
Price vs 50-day SMA	-65.41%
Relative volume	0.01
Return from IPO open	-97.92%
Return from IPO price	-59.4%
RSI	27.74
Sharpe ratio	-1.91
Sharpe ratio (3Y)	0.41
Sortino ratio	-2.95
Sortino ratio (3Y)	0.89
Volume	38.5K
Weekly RSI	29.96
YTD price change	-89.78%
YTD total return	-89.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	706.2K
Float percentage	85.14%
Shares change (QoQ)	6.67%
Shares change (YoY)	52%
Shares held by insiders	9.29%
Shares held by institutions	3.41%
Shares outstanding	829.4K
Short % of float	1.85%
Short % of shares	1.58%
Short ratio	0.8 days

Deeper analysis on NXL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NXL report

Is a complete NXL research report available?

No complete published report is available for Nexalin Technology, Inc. (NXL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Nexalin Technology, Inc. (NXL)

Price

Financial snapshot

Fair-value bridge

Latest news · NXL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NXL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NXL

Frequently asked questions